MPO and acute coronary syndrome: Additional studies demonstrated an increased cardiac risk with elevated serum levels of MPO in patients with acute coronary syndromes, and an increased odds ratio for major adverse cardiac events in a cohort of patients presenting with chest pains [11, 20–22].